| No. |
topic |
PLACE OF TRIALS |
SPONSOR |
| 1. |
A multicenter study to evaluate the safety and
tolerability of Tirofiban in Patients Undergoing Intracoronary Stent
placement. |
1. Institut Jantung Negara (IJN)
2. Hospital Universiti |
Merck, Sharp & Dohme |
| 2. |
A double-blind placebo controlled clinical
end-points trial of Lamivudine in patients with Hepatitis B related
cirrhosis. |
1. Hospital Kuala Lumpur2. Hospital Queen Elizabeth,
Kota Kinabalu
3. Hospital Universiti |
Glaxo-Wellcome (M) Sdn. Bhd. |
| 3. |
A multicenter, randomised, double-blind, double
dummy, parallel group study to establish equivalance of
Beclamethasone Diproprionate 500µg bd via the reservoir powder
inhalation device (RPID) with Beclomethasone Diproprionate 2 x 250µg
bd via the metered dose inhaler (MDI) (PBKD870481A) over 12 weeka in
adolescents and adults with asthma. |
1. Hospital Kuala Lumpur
2. Hospital Sultanah Aminah, Johor
Bahru
3. Hospital Queen Elizabeth, Kota
Kinabalu
4. Hospital USM |
Glaxo-Wellcome (M) Sdn. Bhd. |
| 4. |
To demonstrate the efficacy and safety of
Labucavir 200mg QD in comparison with placebo in subjects with
chronic Hepatitis B infection. |
1. Department of Medicine, Hospital Universiti
2. Department of Medicine, Hospital
Kuala Lumpur |
Bristol-Myers Squibb (M) Sdn. Bhd. |
